Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 10, 2008, Pages 901-906

  Garcia Paez, J I ^a   Tengan, F M ^a   Barone, A A ^a   Levin, A S ^a   Costa, S F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD FLOW; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PNEUMONIA; PRIMARY INFECTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SECONDARY INFECTION; STENOTROPHOMONAS MALTOPHILIA;

ADULT; AGED; APACHE; BACTEREMIA; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA;

EID: 53549102729     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0518-2     Document Type: Article

References (26)

1. CH Lai CY Chi HP Chen 2004 Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia J Microbiol Immunol Infect 37 350 358
2. SD Hanes K Demirkan E Tolley 2002 Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients Clin Infect Dis 35 228 235
3. RR Muder AP Harris S Muller 1996 Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes Clin Infect Dis 22 508 512
4. A Micozzi M Venditti M Monaco 2000 Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies Clin Infect Dis 31 705 711
5. MA Victor M Arpi B Bruun 1994 Xanthomonas maltophilia bacteremia in immunocompromised hematological patients Scand J Infect Dis 26 163 170
6. ND Friedman TM Korman CK Fairley 2002 Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes J Infect 45 47 53
7. LS Elting N Khardori GP Bodey 1990 Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors Infect Control Hosp Epidemiol 11 134 138
8. MD del Toro J Rodríguez-Baño M Herrero 2002 Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study Medicine (Baltimore) 81 228 239
9. Y Carmeli MH Samore 1997 Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study Clin Infect Dis 24 1131 1134
10. M Denton KG Kerr 1998 Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Clin Microbiol Rev 11 57 80
11. E Senol J DesJardin PC Stark 2002 Attributable mortality of Stenotrophomonas maltophilia bacteremia Clin Infect Dis 34 1653 1656
12. WS Wang CP Liu CM Lee 2004 Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan J Microbiol Immunol Infect 37 359 365
13. MD del Toro J Rodríguez-Baño L Martínez- Martínez 2006 Características epidemiológicas, clínicas y pronósticas de la infección por Stenotrophomonas maltophilia Enferm Infecc Microbiol Clin 24 4 9
14. S Tsiodras D Pittet Y Carmeli 2000 Clinical implications of Stenotrophomonas malthophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals Scand J Infect Dis 32 651 656
15. S Nseir C Di Pompeo H Brisson 2006 Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome Crit Care 10 R143
16. WR McCabe GG Jackson 1962 Gram-negative bacteremia. I. Etiology and ecology Arch Intern Med 110 847 855
17. JL Vincent R Moreno J Takala 1996 The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 707 710
18. WA Knaus EA Draper DP Wagner 1985 APACHE II: a severity of disease classification system Crit Car Med 13 818 829
19. JS Garner WR Jarvis TG Emori 1988 CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 128 140
20. [No authors listed] (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
21. Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA
22. G Aisenberg KV Rolston BF Dickey 2007 Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004 Eur J Clin Microbiol Infect Dis 26 13 20
23. U Metan O Uzun 2005 Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia Antimicrob Agents Chemother 49 3980 3981
24. AJ Morrison Jr KK Hoffmann RP Wenzel 1986 Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital J Clin Microbiol 24 52 55
25. AC Nicodemo JI Garcia Paez 2007 Antimicrobial therapy for Stenotrophomonas maltophilia infections Eur J Clin Microbiol Infect Dis 26 229 237
26. M Boktour H Hanna S Ansari 2006 Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients Cancer 106 1967 1973